Efficacy of Rivaroxaban vs. Warfarin in Patients With Acute Left Ventricular Thrombus Following Myocardial Infarction: An Open-Label Randomized Controlled Trial RIVAWAR Trial

The Acute Myocardial Infarction (RIVAWAR) trial is an investigator-initiated, single-center, open-label, randomized controlled trial designed to evaluate the efficacy and safety of rivaroxaban against warfarin for 3 months in patients with acute left ventricular following acute myocardial infarction.

Routine Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation: The British Heart Foundation (BHF) PROTECT-TAVI Trial

Cerebral embolic protection (CEP) devices are available and approved for use in transcatheter aortic valve replacement (TAVR). The BHF PROTECT-TAVI trial is a UK-based randomized trial conducted to evaluate whether routine use of Sentinel CEP in TAVR procedures would reduce the incidence of clinical stroke.

Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

This study sought to examine the five-year clinical and hemodynamic outcomes with transcatheter aortic valve replacement (TAVR) compared to traditional aortic valve replacement (SAVR) in patients from the Evolut Low-Risk trial (1:1 randomization).

Two-Year Outcomes of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The Triluminate Pivotal Trial

This study provides the longest available randomized follow-up data of the tricuspid edge-to-edge repair (TEER) with the TriClip device.

Fractional Flow Reserve Guided Percutaneous Coronary Intervention Compared With Bypass Surgery: Final Five-Year Results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3 Trial

For revascularization of multivessel disease, FAME 3 is the first contemporary randomized controlled trial of coronary artery bypass graft surgery (CABG) versus percutaneous coronary intervention (PCI).

Clopidogrel vs. Aspirin for Long-Term Maintenance Monotherapy in Patients With High Ischemic Risk After Percutaneous Coronary Intervention

The study compares the efficacy and safety of clopidogrel versus aspirin monotherapy after completion of standard dual antiplatelet therapy (DAPT) among high-risk patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES).

Serial Severity Assessment in Advanced Stages of AMI-Cardiogenic Shock Requiring Micro-Axial Flow Pump Support

Published in JSCAI, this study aimed to assess the impact of micro-axial flow pump (mAFP) devices on hemodynamic parameters and the burden of vasoactive medications in patients with acute myocardial infarction complicated by cardiogenic shock who presented in advanced stages (SCAI stage D or E).